Search News Archives
Follow us on
Conferences | Events

Media Partners

 

Frost & Sullivan gives an overview of the Global Automated Biobanking market

publication date: Jun 7, 2012
 | 
author/source: Frost & Sullivan
Frost and Sullivan

Robotics to aid and drive long term vision of truly personalised medicine

Given the increasing demand for long-term storage of clinical samples, compound stores are becoming increasingly important. Same is the case with automated liquid handling units that can perform blood fractionation, sample preparation, capping and decapping of vials, automated pipetting and sample transfers with the help of robotic arms.

The Laboratory Information Management System (LIMS) and the consumable sector are continuously evolving to allow integration of various workflow processes such as tracking of samples, customer billing, online sample request and centralized web accessible data.

The global automation market for biobanking applications accounted for $818 million in 2011, growing at a CAGR of 8.2 percent. By 2018 it is estimated to reach $1,415.5 million. Europe and North America are the biggest contributors, representing respectively 41 % and 40 % of the revenue generated.

In terms of segments, automated liquid handling and robotics account for 59.3 % followed by Automated Compound Storage & Sample Management Systems with 16.3%, Consumables with 12.8% and LIMS with 11.6%. Each year, around 100 million samples are being added to the biobanks worldwide.

"Adoption of automation in biobanks has bestowed key benefits such as ease of error handling, preserving sample integrity, labour maintenance, energy cost savings", says Ms Divyaa Ravishankar, Senior Research Analyst at Frost & Sullivan.

While increased LIMS capabilities and increased growth in Europe and Asia are some of the opportunities, the Industry still faces some challenges, such as funding and financial maintenance of public biobanking infrastructure and automation in the area of ultra-low cold sample storage and retrieval systems.

"The biobanking equipment market requires continuous improvements in automation, prompting manufacturers to provide open automation products, concludes Ms Divyaa Ravishankar. "As cost increases, biobanks look for flexibility in their automation solutions that will connect with numerous competing instrument platforms thus offering more testing that biobanks require in the long run."

Frost & Sullivan recently organised an on-demand analyst briefing entitled "Automated Biobanking - The Next Big Leap for Biorepositories". The web-conference summarises Ms Ravishankar's findings, looking at the growth of automation within the biobanking sector, identifying the drivers and restraints pertaining to automating biobanks and defining the organisational challenges impeding the uptake of automation.

This web-conference will benefit component manufacturers, distributors, biobanking integration software vendors who are currently supplying tools to automate liquid/sample handling, compound storage and LIMS solutions for biobanks. Understanding the interest of the biobank is crucial to tailor solutions that will help the penetration of their technology.

To receive a presentation of the web-conference and a link to the recording, please send an email to Janique Morvan, Corporate Communications, at janique.morvan@frost.com, with your full contact details.


 

Popular this Month

 

Chromatography in Cannabis Testing

 

New Catalogue of Infectious Disease Antibodies and Antigens

 

Acquisition of B&W Tek takes Metrohm’s Spectroscopy Portfolio to the Next Level

 

Gilson announce the release of the extended mass range VERITY® 1910 MS Detector

 

NanoFCM Opens European Office and Centre of Excellence for Scientific Application Support

 

Hitachi High-Technologies Launches Two New Scanning Electron Microscopes

 

Discovery Park & MedCity to Partner on Prestigious Angels In MedCity Programme

 

Merck Lectureship 2019 Awarded to Susumu Kitagawa

 

BioCity Invests in Carbon Recycling Start-Up, Deep Branch Biotechnology

 

Agilent Announces Unique Portfolio to Advance Immunotherapy

 

 


 

Can't find what you are looking for?

Search by company or by product


Company Name:

Product:


 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd

 


 

New Back 2 Basics Promotional Offers and New Products from SLS out Now!

Download | View online